Royalty Pharma Plc Stock Statistic Functions Beta
| RPRX Stock | USD 26.66 0.06 0.23% |
| Symbol |
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Royalty Pharma Plc correlated with the market. If Beta is less than 0 Royalty Pharma generally moves in the opposite direction as compared to the market. If Royalty Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Royalty Pharma Plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Royalty Pharma is generally in the same direction as the market. If Beta > 1 Royalty Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Royalty Pharma Technical Analysis Modules
Most technical analysis of Royalty Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Royalty from various momentum indicators to cycle indicators. When you analyze Royalty charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Royalty Pharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Royalty Pharma Plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Royalty Pharma Plc based on widely used predictive technical indicators. In general, we focus on analyzing Royalty Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Royalty Pharma's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Royalty Pharma's intrinsic value. In addition to deriving basic predictive indicators for Royalty Pharma, we also check how macroeconomic factors affect Royalty Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0173 | 0.0193 | 0.0285 | 0.0361 | Price To Sales Ratio | 7.22 | 7.74 | 5.34 | 5.07 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.